FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+41.78%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$642M
AUM Growth
+$642M
(+41%)
Cap. Flow
+$43.5M
Cap. Flow
% of AUM
6.77%
Top 10 Holdings %
Top 10 Hldgs %
58.84%
Holding
55
New
3
Increased
31
Reduced
11
Closed
–
Top Buys
| 1 |
Ionis Pharmaceuticals
IONS
|
$18.8M |
| 2 |
Omnicell
OMCL
|
$17.2M |
| 3 |
Heron Therapeutics
HRTX
|
$14.1M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$12M |
| 5 |
SHPG
Shire pic
SHPG
|
$8.4M |
Top Sells
| 1 |
Tandem Diabetes Care
TNDM
|
$62.3M |
| 2 |
Xencor
XNCR
|
$5.03M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$4.03M |
| 4 |
Globus Medical
GMED
|
$3.77M |
| 5 |
HealthStream
HSTM
|
$3.55M |
Sector Composition
| 1 | Healthcare | 84.94% |
| 2 | Communication Services | 3.88% |
| 3 | Energy | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
NeoGenomics
NEO
$1.13B
| $67.7M | 10.54% | 5,162,063 +401,731 | +8% | +$5.27M |
|
|
2
Tandem Diabetes Care
TNDM
$845M
| $41.9M | 6.53% | 1,904,260 -2,829,978 | -60% | -$62.3M |
|
|
ARRY
3
DELISTED
Array Biopharma Inc
ARRY
| $40.1M | 6.25% | 2,391,575 +716,427 | +43% | +$12M |
|
|
SHPG
4
DELISTED
Shire pic
SHPG
| $38.8M | 6.04% | 229,721 +49,745 | +28% | +$8.4M |
|
5
AtriCure
ATRC
$1.84B
| $37.3M | 5.81% | 1,380,405 +212,733 | +18% | +$5.75M |
|
|
6
Omnicell
OMCL
$1.5B
| $34.9M | 5.44% | 666,109 +327,996 | +97% | +$17.2M |
|
|
7
Heron Therapeutics
HRTX
$207M
| $32.5M | 5.06% | 836,737 +363,462 | +77% | +$14.1M |
|
8
Harvard Bioscience
HBIO
$22M
| $31.8M | 4.96% | 5,951,014 +509,724 | +9% | +$2.73M |
|
|
IMMU
9
DELISTED
Immunomedics Inc
IMMU
| $27.4M | 4.27% | 1,157,498 +137,578 | +13% | +$3.26M |
|
10
Ligand Pharmaceuticals
LGND
$3.15B
| $25.4M | 3.95% | 122,463 +5,655 | +5% | +$1.17M |
|
|
MODN
11
DELISTED
MODEL N, INC.
MODN
| $24.9M | 3.88% | 1,339,922 +269,899 | +25% | +$5.02M |
|
|
12
Xencor
XNCR
$580M
| $20.8M | 3.24% | 561,807 -135,949 | -19% | -$5.03M |
|
|
13
Ionis Pharmaceuticals
IONS
$6.79B
| $20.6M | 3.21% | 494,347 +451,883 | +1,064% | +$18.8M |
|
14
Nektar Therapeutics
NKTR
$568M
| $18.3M | 2.85% | 374,251 +74,165 | +25% | +$3.62M |
|
|
OXFD
15
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $16M | 2.49% | 1,240,391 +613,806 | +98% | +$7.91M |
|
|
CSII
16
DELISTED
Cardiovascular Systems, Inc.
CSII
| $15.8M | 2.45% | 487,207 +17,520 | +4% | +$567K |
|
17
Halozyme
HALO
$8.56B
| $15M | 2.34% | 889,729 +386,700 | +77% | +$6.52M |
|
18
Codexis
CDXS
$246M
| $12.1M | 1.89% | 841,419 +207,754 | +33% | +$2.99M |
|
|
NVRO
19
DELISTED
NEVRO CORP.
NVRO
| $9.28M | 1.44% | 116,224 -50,520 | -30% | -$4.03M |
|
|
XENT
20
DELISTED
Intersect ENT, Inc
XENT
| $8.53M | 1.33% | 227,883 +38,652 | +20% | +$1.45M |
|
21
Dynavax Technologies
DVAX
$1.19B
| $8.37M | 1.3% | 548,777 +95,143 | +21% | +$1.45M |
|
22
Veracyte
VCYT
$2.39B
| $8.24M | 1.28% | 881,983 +32,417 | +4% | +$303K |
|
|
NVTR
23
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $7.87M | 1.23% | 383,245 -30,401 | -7% | -$624K |
|
|
KTWO
24
DELISTED
K2M Group Holdings, Inc
KTWO
| $6.57M | 1.02% | 292,143 +17,075 | +6% | +$384K |
|
25
Bio-Techne
TECH
$8.5B
| $6.08M | 0.95% | 41,089 +2,434 | +6% | +$360K |
|